Search results for "GD2"

showing 7 items of 7 documents

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma

2021

Simple Summary Osteosarcoma, Ewing’s sarcoma, and H3K27M-mutant diffuse midline glioma are rare but aggressive malignancies occurring mainly in children. Due to their rareness and often fatal course, drug development is challenging. Here, we repurposed the existing drugs dinutuximab and eliglustat and investigated their potential to directly target or indirectly modulate the tumor cell-specific ganglioside GD2. Our data suggest that targeting and/or modulating tumor cell-specific GD2 may offer a new therapeutic strategy for the above mentioned tumor entities. Abstract The ganglioside GD2 is an important target in childhood cancer. Nevertheless, the only therapy targeting GD2 that is approve…

0301 basic medicineCancer Researchlcsh:RC254-282Article03 medical and health sciences0302 clinical medicineNeuroblastomaGliomaosteosarcomaH3K27M-mutant diffuse midline gliomamedicineGangliosidegangliosidebusiness.industrydinutuximabDinutuximabEwing's sarcomaCancerGD2eliglustatlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.disease030104 developmental biologyOncologyganglioside; GD2; dinutuximab; eliglustat; miglustat; H3K27M-mutant diffuse midline glioma; Ewing’s sarcoma; osteosarcoma030220 oncology & carcinogenesisCancer researchmiglustatSarcomaEwing’s sarcomabusinessEliglustatCancers; Volume 13; Issue 3; Pages: 520
researchProduct

Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets

2021

In this issue, Coronado et al. attempt to improve our understanding of the factors affecting the response to immunotherapy in a large subset of high‐risk neuroblastoma with hemizygous deletion of chromosome 11q. By using several computational approaches, the authors study potential transcriptional and post‐transcriptional pathways that may affect the response to immunotherapy and further be leveraged therapeutically in a biomarker‐directed fashion.

0301 basic medicineMaleCancer Researchmedicine.medical_treatmentRetinoic acidchemistry.chemical_compoundNeuroblastoma0302 clinical medicineTumor Microenvironment11q deletion anti-GD2 immunotherapy combination immunotherapy immune cell infiltration miRNAs neuroblastomaMedicineeducation.field_of_studyimmune cell infiltration11q deletionImmunosuppressionGeneral Medicinelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPatologiaNeoplasm ProteinsmicroRNAsSurvival Rateanti‐GD2 therapyOncology030220 oncology & carcinogenesiscombination immunotherapymiRNAsMolecular Medicineimmune checkpoint inhibitionFemaleImmunotherapyChromosome Deletionanti‐GD2 immunotherapyPopulationlcsh:RC254-282Disease-Free Survival03 medical and health sciencesImmune systemNeuroblastomaGeneticsImmune ToleranceHumanseducationRetrospective Studiesbusiness.industryChromosomes Human Pair 11Immunotherapymedicine.diseaseImmune checkpointBlockade030104 developmental biologychemistryCancer researchCommentarybusiness
researchProduct

ESR response to gamma-rays of alanine pellets containing B(OH)3 or Gd2O3.

2007

ESR response to gamma-irradiation (1-50 Gy) of blends containing alanine and either B(OH)(3) or Gd(2)O(3) is reported. The sensitivity of the alanine--B(OH)(3) blend is comparable to the sensitivity of pure alanine, although its lowest detectable dose, LDD, is smaller ( approximately 1.3 Gy) than that of pure alanine ( approximately 2.9 Gy). Alanine with Gd(2)O(3) is about two times more sensitive than pure alanine, and its LDD is 0.8 Gy. The better sensitivity and LDD are probably due to the high atomic number (Z=64) of gadolinium, which enhances the interaction probability with photons and, consequently, the radical yield. This study suggests that other high-Z atoms may be useful for incr…

AlanineHigh atomic numberRadiationAlanineGadoliniumRadiochemistryPelletsElectron Spin Resonance Spectroscopychemistry.chemical_elementGadoliniumESR; Alanine; B(OH)3; Gd2O3; Sensitivity; Mass energy absorption coefficientMass energy absorption coefficientSensitivitychemistryBoric AcidsIsotopesGd2O3Gamma RaysYield (chemistry)RadiometryB(OH)3ESRBoronApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
researchProduct

ESR RESPONSE TO 60 CO-RAYS OF AMMONIUM TARTRATE PELLETS USING GD2O3 AS ADDITIVE.

2007

This work presents experimental results regarding a new ammonium tartrate blend for ESR dosimetry, with a higher sensitivity and a lower lowest detectable dose (LDD) to 60 Co -rays than the recently used pure ammonium tartrate. The blend composed by ammonium tartrate and gadolinium-oxide (Gd2 O3 ) shows a greater sensitivity (∼2 times) and a smaller LDD than ammonium tartrate. The increased sensitivity was mainly attributed to the great atomic number (Z = 64) of gadolinium, that increases the effective atomic number of the blend; the interaction probability with photons and consequently the radical yield is therefore enhanced. Moreover ammonium tartrate with Gd2 O3 has a linear dose respons…

ESR; Ammonium tartrate; Gd2O3–ammonium tartrateESRAmmonium tartrateGd2O3–ammonium tartrate
researchProduct

Estudio de marcadores de enfermedad mínima residual en neuroblastoma y de su posible aplicación clínica

2016

El neuroblastoma es el tumor sólido extracraneal más frecuente en la infancia y el cuarto en frecuencia en el conjunto global de neoplasias infantiles. Su incidencia en nuestro país, según el RNTI oscila entre 8-10 casos por millón de niños y año, por lo que su frecuencia supone alrededor de un 8-10% de todos los tumores en niños. Sin embargo, es el responsable de aproximadamente un 15% del total de muertes provocadas por cáncer pediátrico. La edad media del diagnóstico es de 22 meses, dos tercios de los casos se presentan antes de los 5 años de edad y en un 97% los pacientes tienen menos de 10 años. El tumor es más común en niños que en niñas, siendo el ratio niño/niña aproximadamente 1,3/…

Enfermedad Mínima ResidualGD2Factor pronóstico clínico:CIENCIAS MÉDICAS [UNESCO]NeuroblastomaGAGEDCXUNESCO::CIENCIAS MÉDICASTHPCR cuantitativa en tiempo realMAGEA1InmunocitologíaMAGEA3
researchProduct

Improvement of the LET sensitivity in ESR dosimetry for -photons and thermal neutrons through gadolinium addition

2007

Abstract We investigated the ESR response of new materials, alanine and ammonium tartrate to which gadolinium was added. The addition of gadolinium enhances sensitivity for Co 60 γ -photons because of its high atomic number ( Z = 64 ) and an enhancement of sensitivity for thermal neutrons because of its high thermal neutron cross section and high linear energy transfer (LET) secondary particles produced after the reaction with neutrons. In particular, in this paper we analyzed the microwave power saturation properties of dosimeters of alanine and ammonium tartrate with or without gadolinium exposed to different LET beams. The power saturation trends of dosimeters exposed to photons and to t…

PhysicsRadiationDosimeterammonium tartrateGadoliniumPhysics::Medical PhysicsRadiochemistrychemistry.chemical_elementLinear energy transferRadiationNeutron temperatureGd2O3-ammonium tartratechemistry.chemical_compoundGd2O3-alaninechemistryLETDosimetryCondensed Matter::Strongly Correlated ElectronsAmmoniumNeutronalanineInstrumentationESRRadiation Measurements
researchProduct

Améliorer les effets anti-tumoraux des lymphocytes T folliculaires helper (Tfh) en ciblant la communication intercellulaire entre Tfh et Th2.

2019

It is now accepted that the immune system plays a critical role in cancers evolution (Hanahan et al., 2011). In this context, current understanding of the adaptive immune response made it a prime target. T CD4 cells, the main players of the adaptive immune system component, are known to possess distinct roles in the control of tumour growth. Thereby, Th2 and Tfh cells, both known to activate B cells in pathogenic infections, present antagonistic roles in cancer. Indeed, numerous studies demonstrate that Th2 cells are correlated with disease progression (especially via IL-4 secretion) (Koller et al., 2010 ; Roca et al., 2012), whereas Tfh cells are associated with a good prognosis for the pa…

Th2 cellsCommunication celluaireTh2[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyPgd2Tfh[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyTfh cellsHpgdsCell communicationCancer
researchProduct